Introduction {#S1}
============

We here report the first series of culture and/or PCR -- documented *Francisella tularensis* otomastoiditis. Intriguingly, the three patients had all independently practiced canyoneering between 2008 and 2014 in the same French river several days before clinical signs onset.

Patient 1 {#S1-1}
---------

The observation has already been published as a single case report by Gürkov et al. ([@B1]), but the epidemiologic link with the present series was uncovered by Guerpillon and Gürkov when retrospectively questioning the patient. Briefly, in summer 2008, a 27-year-old female with no comorbidity presented with acute otitis media and retropharyngeal swelling after 5 weeks of empirical treatment by subsequent amoxicillin, cefuroxim, and ceftriaxone. Computed Tomography scan (CT-scan) revealed a retropharyngeal abscess and mastoiditis.

Patient 2 {#S1-2}
---------

The following summer (2009), a 39-year-old female with no known comorbidity presented to an Ear Nose and Throat (ENT) emergency unit for vestibular disorders, conductive deafness, and fever. She reported being under clavulanic acid--amoxicilin for the past 2 weeks due to a sore throat with adenopathies. CT-scan confirmed the unilateral right otitis media and mastoiditis.

Patient 3 {#S1-3}
---------

The third case occurred in summer 2014 and involved a 43-year-old canyoneering instructor with no notable medical history. After 5 days suffering from right otalgia with accompanying hearing loss and asthenia, the patient received an empirical course of oral amoxicillin followed by oral cefpodoxim and ibuprofen from his general practitioner. No clinical improvement was observed. Thirteen days after the onset of clinical signs, the patient began suffering from right facial paralysis and thus consulted to an ENT department. Upon clinical examination, homolateral sensorineural deafness and right-side tonsilitis with a subdigastric adenopathy were noted. Peripheral grade 6 facial paralysis was confirmed ([@B2]). Otoscopy of the right side showed inflammatory stenotic external auditory canal. A paracentesis was performed, leading to a purulent discharge. Biological examination revealed an inflammatory syndrome (Table [1](#T1){ref-type="table"}). CT-scan (Figure [1](#F1){ref-type="fig"}) confirmed the acute otitis media of the right ear, with blockage of the middle ear and the tympanic cavity, partial blockage of the mastoid cells, and the internal portion of the external auditory canal, as well as a lateral pharyngeal adenopathy on the right side (16 mm × 19 mm) and tonsillitis. Upon hospital admission, piperacillin--tazobactam (12 g/day) with a daily injection of amikacin (15 mg/kg) and topical ofloxacin (200 mg/day) treatment was initiated. Prednisone (1 mg/kg/day, 6 days) was added to treat the facial paralysis.

###### 

**Characteristics of patients in a series of *Francisella tularensis* subsp. *holarctica* otomastoiditis**.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                   Patient 1 ([@B1])                              Patient 2                                                                     Patient 3
  ---------------------------------------------------------------- ---------------------------------------------- ----------------------------------------------------------------------------- -------------------------------------------------------------
  Date                                                             July 2008                                      July 2009                                                                     May 2014

  Gender                                                           Female                                         Female                                                                        Male

  Age (years old)                                                  27                                             39                                                                            43

  Incubation (days)                                                \<7                                            10                                                                            3--7

  Clinical presentation                                            Pharyngitis                                    Pharyngitis                                                                   Tonsillitis (right-side)

  Purulent left otitis media                                       Purulent right otitis media                    Purulent right otitis media                                                   

  Retropharyngeal swelling                                         Submandibular adenopathy                       Subdigastric adenopathy                                                       

  Complications                                                    Cervical phlegmonous inflammation\             Conductive deafness (40 dB)\                                                  Facial peripheral paralysis\
                                                                   Conductive deafness (15--30 dB)\               Mastoiditis\                                                                  Mixt deafness (40 dB in low pitch and 80 dB in high pitch)\
                                                                   Retropharyngeal abscess\                       Vestibular disorders                                                          Mastoiditis
                                                                   Mastoiditis                                                                                                                  

  CRP upon hospital admission                                      36 mg/L                                        90 mg/L                                                                       155 mg/L

  Empirical treatment active for *Francisella tularensis*          None                                           Ofloxacin (8 days)                                                            Amikacin (5 days)

  Elapsed time between clinical signs onset and diagnosis (days)   44                                             25                                                                            28

  Microbiological diagnostic techniques                            16S PCR Serology                               Culture                                                                       Culture

  *Francisella tularensis-*specific PCR                            16S PCR                                                                                                                      

  *Francisella tularensis*-specific PCR                                                                                                                                                         

  Bacterial etiology                                               *Francisella tularensis* subsp. *holarctica*   *Francisella tularensis* subsp. *holarctica*                                  *Francisella tularensis* subsp. *holarctica*

  Treatment (from diagnosis)                                       Day 1--5: doxycyclin                           Day 0--4: gentamicin                                                          Day 0--45: ciprofloxacin + doxycycline

  Day 1--23: ciprofloxacin                                         Day 0--25: ciprofloxacin                       Day 45--78: no treatment                                                      

  Day 11--23: gentamicin                                           Day 89: transtympanic tube                     Day 78--108: doxycyclin                                                       

  Paracentesis                                                                                                                                                                                  

  Lesions needle aspiration                                                                                                                                                                     

  Surgical drainage                                                                                                                                                                             

  Outcome                                                          Conductive deafness (8-month follow-up)        Conductive deafness (10 dB) minor vestibular disorders (10-month follow-up)   Asymptomatic (2-month follow-up)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![**Mastoid CT scan of patient 3**. **(A)** High-resolution axial section focus of the right temporal bone. Acute otitis media with tympanomastoid homogenous opacity inflammatory filling of the whole tympanic cavity (![](fmed-03-00009-i001.jpg)) and mastoid cells (\*). **(B)** Swelling related to the right tonsillitis (\*).](fmed-03-00009-g001){#F1}

Background {#S2}
==========

*Francisella tularensis* is a bacterial agent of pleomorphic anthropozoonoses, such as ulceroglandular or oropharyngeal syndromes and pneumonia, depending on the route of inoculation. Acute otitis tularemia is excessively rare; only two cases have been described so far ([@B1], [@B3]). Contaminated water is known as the route of oropharyngeal infection when ingested ([@B4]--[@B7]). However, to our knowledge, direct skin contact when bathing has never been pointed out as the source of infection.

Discussion {#S3}
==========

Patient 1 {#S3-1}
---------

16S rDNA polymerase chain reaction (16S PCR) testing of an adenopathy aspirated fluid revealed the presence of *F. tularensis* subsp *holarctica* DNA. The positive serology performed concomitantly corroborated the results, leading to a final diagnosis 44 days after the onset of the symptoms. Adapted antibiotic treatment (Table [1](#T1){ref-type="table"}) combined with paracentesis and repeated needle aspirations of the suppurative lesions remained inefficient. Only open surgical drainage allowed to cure the infection. Finally, the patient, a music teacher, suffered from a lasting conductive deafness of 15--30 dB ([@B1]).

The patient reported canyoneering practice in the river Le Grenant during her journey to France, 7 days before the clinical onset.

Patient 2 {#S3-2}
---------

Bacteriological analysis of an otorrhea sample yielded monomicrobial culture of *F. tularensis* after 15 days incubation (i.e., 25 days after the onset of symptoms). The expertise of the French National Reference Center for *Francisella* allowed the identification of the subspecies *holarctica* by specific PCR. A first 1-week course of oral ofloxacin (200 mg twice a day) leading to partial clinical improvement only, a combined treatment with oral ciprofloxacin for 25 days and gentamicin for 5 days was initiated (Table [1](#T1){ref-type="table"}). Ten months after the end of treatment, conductive deafness (10 dB) and minor vestibular disorders still remained.

Canyoneering in the river Le Grenant 10 days before the onset of the symptoms was the only exposure factor revealed by the medical history.

Patient 3 {#S3-3}
---------

The bacteriological analysis of the paracentesis pus sample yielded a monomicrobial culture of Gram negative bacilli after 3 days incubation, identified as *F. tularensis* by 16S PCR ([@B4]), and confirmed as *F. tularensis* subsp. *holartica* by the French National Reference Center using specific PCR. The facial paralysis, angina, and asthenia regressed after 5 days of amikacin/piperacillin--tazobactam treatment; the subdigastric adenopathy diminished while persistent. Antibiotic treatment was then adapted with oral ciprofloxacin and doxycycline plus topical ofloxacin for 45 days. Regarding the hearing loss, repeated audiometric reports revealed improvement of conductive audition despite no restitution *ad integrum*. After 45 days, the patient could not stand anymore the lack of physical activity imposed by fluoroquinolone administration and ceased his treatment. Due to the diagnosis delay and the initial loco-regional extension, he finally complied with the medical team suggestion for another 30 days of doxycycline.

The follow-up MRI (Figure [2](#F2){ref-type="fig"}) and PET scan after 3 months showed satisfactory evolution with a minimal persistence of gadolinium enhancement in the right mastoid, and moderate hyper fixation of the right mastoid cells, respectively, with no other associated bone or tissue anomaly. The patient felt perfectly healthy. Noticeably, as a canyoneering instructor, the patient reported sessions in Le Grenant river (France) 3--7 days before the first clinical signs.

![**Post treatment imaging**. **(A)** Gadolinium-enhanced axial T1 weighted fat-suppressed MRI. Minimal persistence of gadolinium enhancement in the right mastoid. **(B)** PET CT fused image. Good aeration and minimal persistence of 18 FDG uptake in the right mastoid. No other associated bone or tissue anomaly.](fmed-03-00009-g002){#F2}

Concluding Remarks {#S4}
==================

We report here the first series of three cases of *F. tularensis* otomastoiditis, which is an extremely rare localization, and may be related to an aquatic inoculation. Noticeably, the clinical presentation included severe deafness for all patients, possibly with retropharyngeal abscess and/or facial paralysis. Besides, the three cases noticeably occurred independently between 2008 and 2014 after a common exposure to the same French river (Le Grenant) 3--10 days before the clinical symptoms onset, which is consistent with the mean incubation period (3--5 days) ([@B8]). Given the very low incidence of tularemia in France, it is thus likely that the river was the common source of infection to the three cases.

Transmission occurs by ingestion, inhalation, or contact between contaminated liquids and human mucus. Moreover, *F. tularensis* is hosted in rodents and lagomorphs, and can be introduced into watercourses from animal carcasses ([@B9], [@B10]). Strikingly, a tannery was found to be closely located upstream from the canyoneering spot on the river border. Following the report of the case 2 (while not knowing the link of case 1 with the same river), the health authorities initiated a field survey and discovered that wastewater was discharged to the river. Bacteriological analyses of sewage and river water did not detect the presence of *Francisella* DNA, although only small volumes of water samples could be analyzed leading to a possible lack of sensitivity.

Given the complications observed due to the delay of diagnosis and the ineffectiveness of beta-lactams, we insist on this possible etiology in case of otitis media associated with fresh-water ­exposure and persisting after conventional antibiotic courses.
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